Literature DB >> 5059565

Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro.

J M Saavedra, J Axelrod.   

Abstract

The use of a sensitive enzymatic assay demonstrates that tryptamine occurs normally in rat brain. Intracisternal administration of [(14)C]tryptamine results in the formation of N-methyl-and dimethyltryptamine(a psychotomimetic compound)in the rat brain. An enzyme that converts tryptamine and N-methyl-tryptamine to N-methyl-and dimethyltryptamine was found to be present in rat and human brain. The N-methylation of tryptamine was inhibited by normally occurring compounds present in rat brain.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5059565     DOI: 10.1126/science.175.4028.1365

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  LSD and tryptamine effects on sleep/wakefulness and electrocorticogram patterns in intact cats.

Authors:  D C Kay; W R Martin
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

3.  Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.

Authors:  P B Bradley; I Briggs
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

4.  Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.

Authors:  P C Waldmeier; L Maître
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

5.  The occurrence of tryptamine in rat brain and its pharmacological manipulation.

Authors:  A S Horn; S R Snodgrass
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

6.  The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.

Authors:  Dominique Fontanilla; Molly Johannessen; Abdol R Hajipour; Nicholas V Cozzi; Meyer B Jackson; Arnold E Ruoho
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

Review 7.  When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.

Authors:  Tsung-Ping Su; Teruo Hayashi; D Bruce Vaupel
Journal:  Sci Signal       Date:  2009-03-10       Impact factor: 8.192

Review 8.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

Review 9.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

10.  Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.

Authors:  P Jenner; C D Marsden; C M Thanki
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.